Partial Seizures with or Without Secondary Generalization
📧 Sign up to get email alerts when something new happens for Partial Seizures with or Without Secondary Generalization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization [Phase 3]
A Phase 3 trial evaluating brivaracetam as adjunctive therapy in subjects aged 16 and older with partial seizures with or without secondary …
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization [Phase 3]
Phase 3 trial evaluating intravenous brivaracetam as a replacement for oral brivaracetam in Japanese patients aged 16 and older with partial…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization [Phase 3]
This is a multicenter Phase 3 trial evaluating SPM 927 as adjunctive therapy for partial seizures with or without secondary generalization. …